113 related articles for article (PubMed ID: 7701055)
21. Different sensitivity of pain-related chemosensory potentials evoked by stimulation with CO2, tooth pulp event-related potentials, and acoustic event-related potentials to the tranquilizer diazepam.
Thürauf N; Ditterich W; Kobal G
Br J Clin Pharmacol; 1994 Dec; 38(6):545-55. PubMed ID: 7888293
[TBL] [Abstract][Full Text] [Related]
22. Correlation between doses of oxazepam and their effects on performance of a standardised test battery.
Kerr JS; Hindmarch I; Sherwood N
Eur J Clin Pharmacol; 1992; 42(5):507-10. PubMed ID: 1606996
[TBL] [Abstract][Full Text] [Related]
23. The effect of levo-acetyl-carnitine on visual cognitive evoked potentials in the behaving monkey.
Antal A; Bodis-Wollner I; Ghilardi MF; Glover A; Mylin L; Toldi J
Electroencephalogr Clin Neurophysiol; 1993 Apr; 86(4):268-74. PubMed ID: 7682930
[TBL] [Abstract][Full Text] [Related]
24. [WMN: a negative ERPs component related to working memory during non-target visual stimuli processing].
Zhao L; Wei JH
Space Med Med Eng (Beijing); 2003 Oct; 16(5):322-5. PubMed ID: 14753229
[TBL] [Abstract][Full Text] [Related]
25. Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.
Franken IH; Nijs I; Pepplinkhuizen L
Psychopharmacology (Berl); 2008 Jan; 195(4):537-46. PubMed ID: 17891382
[TBL] [Abstract][Full Text] [Related]
26. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
[TBL] [Abstract][Full Text] [Related]
27. Age-related differences in performance and stimulus processing in dual task situation.
Hahn M; Wild-Wall N; Falkenstein M
Brain Res; 2011 Sep; 1414():66-76. PubMed ID: 21871612
[TBL] [Abstract][Full Text] [Related]
28. Effects of oxazepam and lorazepam on implicit and explicit memory: evidence for possible influences of time course.
Stewart SH; Rioux GF; Connolly JF; Dunphy SC; Teehan MD
Psychopharmacology (Berl); 1996 Nov; 128(2):139-49. PubMed ID: 8956375
[TBL] [Abstract][Full Text] [Related]
29. Caffeine effects on ERPs and performance in an auditory Go/NoGo task.
Barry RJ; Johnstone SJ; Clarke AR; Rushby JA; Brown CR; McKenzie DN
Clin Neurophysiol; 2007 Dec; 118(12):2692-9. PubMed ID: 17905651
[TBL] [Abstract][Full Text] [Related]
30. Effects of lorazepam and oxazepam on perceptual and procedural memory functions.
Martin J; Matthews A; Martin F; Kirkby KC; Alexander J; Daniels B
Psychopharmacology (Berl); 2002 Nov; 164(3):262-7. PubMed ID: 12424549
[TBL] [Abstract][Full Text] [Related]
31. A comparison of some psychological and physiological effects exerted by zetidoline (DL308) and by oxazepam.
Herbert M; Standen PJ; Short AH; Birmingham AT
Psychopharmacology (Berl); 1983; 81(4):335-9. PubMed ID: 6140700
[TBL] [Abstract][Full Text] [Related]
32. Sedative, memory, and performance effects of hypnotics.
Roehrs T; Merlotti L; Zorick F; Roth T
Psychopharmacology (Berl); 1994 Oct; 116(2):130-4. PubMed ID: 7862941
[TBL] [Abstract][Full Text] [Related]
33. Pupillometry and the vigilance decrement: Task-evoked but not baseline pupil measures reflect declining performance in visual vigilance tasks.
Martin JT; Whittaker AH; Johnston SJ
Eur J Neurosci; 2022 Feb; 55(3):778-799. PubMed ID: 34978115
[TBL] [Abstract][Full Text] [Related]
34. Effects of chlorpromazine on pattern and flash ERGs and VEPs compared to oxazepam and to placebo in normal subjects.
Bartel P; Blom M; Robinson E; Van der Meyden C; Sommers DO; Becker P
Electroencephalogr Clin Neurophysiol; 1990; 77(5):330-9. PubMed ID: 1697524
[TBL] [Abstract][Full Text] [Related]
35. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients.
Linzmayer L; Semlitsch HV; Saletu B; Böck G; Saletu-Zyhlarz G; Zoghlami A; Gruber D; Metka M; Huber J; Oettel M; Gräser T; Grünberger J
Arzneimittelforschung; 2001; 51(3):238-45. PubMed ID: 11304940
[TBL] [Abstract][Full Text] [Related]
36. Effects of long-term cannabis use on selective attention: an event-related potential study.
Solowij N; Michie PT; Fox AM
Pharmacol Biochem Behav; 1991 Nov; 40(3):683-8. PubMed ID: 1806953
[TBL] [Abstract][Full Text] [Related]
37. Central effects of the diuretic, bendrofluazide.
McDevitt DG; Currie D; Nicholson AN; Wright NA; Zetlein MB
Br J Clin Pharmacol; 1994 Sep; 38(3):249-56. PubMed ID: 7826827
[TBL] [Abstract][Full Text] [Related]
38. Relative abuse liability of diazepam and oxazepam: behavioral and subjective dose effects.
Griffiths RR; McLeod DR; Bigelow GE; Liebson IA; Roache JD
Psychopharmacology (Berl); 1984; 84(2):147-54. PubMed ID: 6438672
[TBL] [Abstract][Full Text] [Related]
39. Late components of lambda responses in cognitive tasks.
Marton M; Szirtes J; Breuer P
Doc Ophthalmol; 1985 Feb; 59(2):199-204. PubMed ID: 3996194
[TBL] [Abstract][Full Text] [Related]
40. Transdermal nicotine: single dose effects on mood, EEG, performance, and event-related potentials.
Knott V; Bosman M; Mahoney C; Ilivitsky V; Quirt K
Pharmacol Biochem Behav; 1999 Jun; 63(2):253-61. PubMed ID: 10371654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
